1317P Real-world Immunotherapy (IO) Rechallenge Outcomes with Nivolumab (NIV) in Advanced Non-Small Cell Lung Cancer (ansclc) in France: LIST Study Interim Results
Annals of Oncology（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined